Keywords: isis, receives, milestone, payment, eli, lilly, california

Isis receives milestone payment from Eli Lilly

Article | 13 February 2006

Print This

California, USA-based Isis Pharmaceuticals says that US drug major Eli Lilly has begun clinical trials of LY2275796, which it licenses ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in